#g2m

Today, on #WorldDownSyndromeDay, we celebrate the power of diversity and the beauty of inclusion. Let’s continue to raise awareness, break barriers, and create a world where everyone’s potential is recognized and valued.

HPV awareness and education is the key for preventing various HPV-related cancers. One of them is cervical cancer, a disease that kills thousands of women every year. Being a virus-borne infection, HPV infections are communicable that can travel among people through skin-to-skin contact (sexual intercourse). There are over 100 strains of HPV, more than 40 of which are passed through sexual contact and can affect your genitals, mouth, or throat. Genes2Me HPV-Q Comprehensive Real-Time PCR kit screens for the presence/absence of HPV in genotypes. Take the test today to determine your risk of HPV.

For more details, Call us at 18001214030 or drop us an email at [email protected] for an Appointment

📢 Join us at #ESHG_2026 for an engaging corporate session exploring how Next-Generation #Sequencing is driving meaningful clinical impact across diverse #healthcare applications.

Beyond the #Genome: Clinical Insights & Real-World Impact Across Liquid Biopsy, #NIPT & #Pharmacogenomics

📅 15 June 2026

🕥 10:30 – 11:30 AM CEST

📍 Room A7, Svenska Mässan, Gothenburg, Sweden

🔗 Register here: https://forms.office.com/r/RDKh8pdCmJ

Discover the latest advancements, #clinical insights, and real-world #applications shaping the future of precision medicine through #genomics.

Hear from leading experts as they discuss:

🔹 Liquid Biopsy in oncology and disease monitoring

🔹 NIPT and the evolving landscape of prenatal screening

🔹 Pharmacogenomics and personalized therapeutic decision-making

Whether you're a clinician, #researcher, geneticist, or healthcare professional, this session offers valuable perspectives on the expanding role of #NGS in modern #medicine.

We look forward to seeing you there!

We’re excited to be at #ESHG_2026 in Gothenburg, #Sweden! 🇸🇪

Join us for our #Corporate_Session:

#NGS Across the Clinical Continuum: Applications, Insights and Impact

📅 June 15, 2026

🕥 10:30 AM – 11:30 AM CEST

📍 A7, Svenska Mässan

Discover how next-generation #sequencing is transforming clinical #applications across diagnostics and precision medicine through expert insights and real-world perspectives.

Visit the #G2M team at Booth #630 from June 13–15 to explore our latest innovations across NGS, #molecular diagnostics, #pharmacogenomics, liquid biopsy, and more.

We look forward to #connecting with you at #ESHG 2026!

#Celebrating the spirit of #togetherness, #gratitude, and new beginnings this Eid-al-Adha. ✨🌙

Wishing you and your #family a joyful and prosperous #Eid filled with peace, #happiness, and cherished #moments.

Empower early detection with the #Genes2Me BRCA NGS Assay — enabling comprehensive hereditary risk assessment for Breast & Ovarian #Cancer. With complete #BRCA1&2 CDS coverage, CNV detection, and advanced interpretation support via #CliSeq Interpreter, the assay helps drive timely, informed clinical decisions for better women’s #health outcomes.

Visit our website for more information: https://genes2me.com/ngs/oncology-breast-cancer-testing-panel

This Women’s Health #Awareness Month, #Genes2Me reinforces its vision of empowering women through early diagnosis, precision molecular #diagnostics, and preventive healthcare. Together, let’s prioritize awareness, timely #screening, and informed #healthcare decisions for a stronger, healthier future for every #woman!

🧬 Every patient responds differently to treatment - and #pharmacogenomics is helping us understand why.

On #GlobalPharmacogenomicsDay, we celebrate the power of genetics in enabling safer, smarter, and more personalized #healthcare decisions. From reducing adverse #drug reactions to improving therapeutic outcomes, #PGx is shaping the future of precision #medicine.

At #Genes2Me, we are proud to contribute to this transformation through the #Med4Me PGx Assay - empowering clinicians with actionable genetic insights for optimized therapy selection.

From #Genetic Insight to Therapeutic Precision.